Literature DB >> 17474892

Diagnostic clues to megaloblastic anaemia without macrocytosis.

C W J Chan1, S Y H Liu, C S B Kho, K H T Lau, Y S Liang, W R Chu, S K E Ma.   

Abstract

Masking of the macrocytic expression of megaloblastic anaemia (MA) by coexisting thalassaemia, iron deficiency and chronic illness has been widely reported. We described the haematological and clinical features of 20 Chinese patients with MA presenting with mean corpuscular volume (MCV) < or =99 fl, and analysed the steps leading to the final diagnosis of MA with concomitant thalassaemia trait (n = 11), thalassaemia trait and iron deficiency (n = 3), iron deficiency (n = 4) and chronic illness (n = 2). We also compared the haematological characteristics of this group of patients with a group of normocytic anaemic patients without vitamin B(12)/folate deficiency, and identified certain laboratory information useful for differentiating the two groups. Statistically significant parameters included the mean values of haemoglobin, MCV, red cell distribution width (RDW), reticulocyte index, platelet count and serum bilirubin. All provided clues to maturation disorders within the marrow. A decision flowchart for the diagnosis of MA without macrocytosis was proposed. In the studied population, by using the parameters of haemoglobin <10 g/dl, MCV 80-99 fl, RDW > or = 16% and reticulocyte index < or = 2% as indicators, there was a 58% chance that a patient had MA without macrocytosis if he/she had all the four indicators, and a 2.2% chance of having it if he/she did not have these indicators. We emphasized the importance of including peripheral blood smear examination in the diagnostic procedures for such patients, as well as the importance of paying attention to patients' medical history, racial background and previous MCV value.

Entities:  

Mesh:

Year:  2007        PMID: 17474892     DOI: 10.1111/j.1751-553X.2007.00911.x

Source DB:  PubMed          Journal:  Int J Lab Hematol        ISSN: 1751-5521            Impact factor:   2.877


  6 in total

1.  How I treat cobalamin (vitamin B12) deficiency.

Authors:  Ralph Carmel
Journal:  Blood       Date:  2008-07-07       Impact factor: 22.113

2.  Cation Exchange High Performance Liquid Chromatography for Diagnosis of Haemoglobinopathies.

Authors:  P K Gupta; H Kumar; S Kumar; M Jaiprakash
Journal:  Med J Armed Forces India       Date:  2011-07-21

3.  Association of vitamin B12 deficiency and metformin use in patients with type 2 diabetes.

Authors:  Sun-Hye Ko; Sun-Hee Ko; Yu-Bae Ahn; Ki-Ho Song; Kyung-Do Han; Yong-Moon Park; Seung-Hyun Ko; Hye-Soo Kim
Journal:  J Korean Med Sci       Date:  2014-07-11       Impact factor: 2.153

4.  Higher prevalence of metformin-induced vitamin B12 deficiency in sulfonylurea combination compared with insulin combination in patients with type 2 diabetes: a cross-sectional study.

Authors:  Donghoon Kang; Jae-Seung Yun; Sun-Hye Ko; Tae-Seok Lim; Yu-Bae Ahn; Yong-Moon Park; Seung-Hyun Ko
Journal:  PLoS One       Date:  2014-10-09       Impact factor: 3.240

5.  Relationship between cobalamin and folate deficiencies and anemia in dogs.

Authors:  Emma Stanley; Elizabeth Appleman; Ariel Schlag; Andrea Siegel
Journal:  J Vet Intern Med       Date:  2018-11-29       Impact factor: 3.333

6.  Association between metformin dose and vitamin B12 deficiency in patients with type 2 diabetes.

Authors:  Jiwoon Kim; Chul Woo Ahn; Sungsoon Fang; Hye Sun Lee; Jong Suk Park
Journal:  Medicine (Baltimore)       Date:  2019-11       Impact factor: 1.817

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.